logo
Explained: Why Reliance Industries shares fell 3% after reporting highest-ever profit

Explained: Why Reliance Industries shares fell 3% after reporting highest-ever profit

Time of India20 hours ago
Shares of billionaire Mukesh Ambani-led conglomerate
Reliance Industries
(RIL) fell 2.7% to Rs 1,436.85 on BSE in Monday's trade despite reporting its highest-ever profit and EBITDA in Q1 results announced on Friday. The Rs 30,783 crore profit was significantly boosted by the sale of
Asian Paints
stake, worth Rs 8,924 crore, and lower-than-expected interest expenses and taxes. Multiple brokerages said the numbers missed estimates across key business segments.
Jefferies
delivered a blunt assessment stating that consolidated EBITDA was 3% below their estimates, with O2C and Retail segments falling 5% and 4% below expectations, respectively. The global brokerage maintained its Buy rating with a target price of Rs 1,726 but highlighted that core Retail grew only 8% year-on-year as electronics sales slowed due to early monsoon and space addition lagged behind expectations.
Explore courses from Top Institutes in
Select a Course Category
Operations Management
Data Science
Data Analytics
Cybersecurity
Degree
Project Management
Digital Marketing
Artificial Intelligence
others
Public Policy
Finance
Others
Data Science
CXO
Design Thinking
Leadership
Management
MCA
Product Management
PGDM
healthcare
MBA
Healthcare
Skills you'll gain:
Quality Management & Lean Six Sigma
Analytical Tools
Supply Chain Management & Strategies
Service Operations Management
Duration:
10 Months
IIM Lucknow
IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics
Starts on
Jan 27, 2024
Get Details
Emkay was even more direct about the disappointment, noting that RIL saw a 5% and 7% consolidated EBITDA and adjusted profit miss in Q1FY26 at Rs 429 billion and Rs 181 billion, respectively. This underperformance was attributed to 6% and 5% lower than expected O2C and Retail EBITDA performance.
Also Read |
Is RIL's strong profit growth sustainable amid rising capital expenditure?
The consensus was clear across major brokerages that, despite the headline-grabbing profit figure, the operational performance fell short of expectations across critical business verticals.
Live Events
Reliance Retail, once considered a growth engine, posted disappointing numbers that concerned analysts. Motilal Oswal noted that Reliance Retail's operational EBITDA came in approximately 7% below their estimate due to weaker-than-expected revenue growth of 11% year-on-year compared to their forecast of around 16%.
JPMorgan was particularly concerned about retail momentum, stating that retail growth decelerated to 11% year-on-year while missing estimates. The investment bank maintained its Overweight rating but hiked its target price to Rs 1,695 from Rs 1,568, suggesting cautious optimism despite current headwinds.
The retail weakness was attributed to seasonal factors and slower electronics sales, with Jefferies explaining that electronics performance slowed due to early monsoon conditions and space addition lagged behind planned expansion.
The Oil-to-Chemicals (O2C) business, RIL's traditional cash cow, also underwhelmed analysts with weaker-than-expected performance. Motilal Oswal reported that consolidated O2C EBITDA declined 4% quarter-on-quarter, representing an 8% miss from estimates, as higher retail fuel margins and product cracks were offset by lower volumes due to a planned shutdown.
Nuvama provided additional context explaining that O2C performance was mainly impacted by turnaround activities while Jefferies noted that O2C was affected by refinery shutdown, though they maintained that the refining outlook remains constructive for future periods.
Despite the near-term challenges, analysts remained positive about the segment's prospects, with Emkay noting that refining margins would be supported by refinery closures in Europe and North America, though petrochemical recovery would take additional time to materialize.
Also Read |
Reliance Industries shares tumble after Q1 results. Should you buy, sell or hold?
Jio shines amid broader weakness
The only bright spot in an otherwise mixed quarter was Reliance Jio, which continued its robust performance trajectory. Motilal Oswal highlighted that RJio EBITDA rose approximately 5% quarter-on-quarter, representing a 2% beat over estimates, led by lower operational costs and high incremental EBITDA margins of 97%.
Emkay added that Jio subscriber addition was better than expected at 9.9 million new customers, while average revenue per user (ARPU) grew 1% to Rs 208.8. The telecom arm's strong performance was driven by continued subscriber growth and improved operational margins.
Macquarie provided a segment-wise assessment noting that at the business level, Jio demonstrated strength while retail appeared lacklustre and O2C showed gradual signs of recovery from previous challenging periods.
Despite the mixed quarterly results, RIL management painted an optimistic picture for future growth prospects. The conglomerate has expressed confidence in doubling EBITDA across the entire group by 2029, with growth guidance on Jio and Retail segments calling for doubling earnings within 3-4 years, being reaffirmed by management.
Analysts remained bullish on RIL's new energy initiatives despite current operational challenges. Nuvama characterized the new energy segment as the "largest multidecadal growth driver" and expects the new energy ecosystem to ramp up within 4–6 quarters. The brokerage estimates that a fully integrated 10GW polysilicon-to-module facility by end-FY26 may add 6% to consolidated profit after tax.
Emkay provided specific timelines indicating that the new energy ecosystem would be fully operational within 4-6 quarters through strategic partnerships, eventually becoming a self-funded model within a few years, with potential for perpetual growth.
Prabhudas Lilladher upgraded the stock from Hold to Accumulate rating, introducing a valuation of Rs 111 per share specifically for the new energy segment, reflecting growing confidence in this emerging business vertical.
Despite the disappointing quarterly performance, most major brokerages maintained positive ratings on
RIL shares
. Jefferies maintained a Buy rating with a target price of Rs 1,726, Morgan Stanley kept an Overweight rating with a target price of Rs 1,617, and Emkay sustained a Buy rating with a target price of Rs 1,600.
Nuvama maintained a Buy rating with a target price of Rs 1,767, Motilal Oswal kept a Buy rating with a target price of Rs 1,700, and JPMorgan maintained an Overweight rating with an increased target price of Rs 1,695.
HSBC
and Nomura both maintained Buy ratings with target prices of Rs 1,630 and Rs 1,600, respectively.
However, Macquarie provided a cautionary note stating they believe Reliance's share price could see near-term moderation following this results announcement while maintaining their Outperform rating with a Rs 1,500 target price.
ETMarkets WhatsApp channel
)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Titan to buy 67% in Dubai's Damas jeweller for ₹1.6k cr
Titan to buy 67% in Dubai's Damas jeweller for ₹1.6k cr

Time of India

time13 minutes ago

  • Time of India

Titan to buy 67% in Dubai's Damas jeweller for ₹1.6k cr

Tanishq owner Titan company buys Damas MUMBAI: Titan, which owns the Tanishq brand, will buy 67% in jewellery retailer Damas from Qatar-listed Mannai Corporation for AED 695 million ($189 million or Rs 1,630 crore), establishing itself as one of the prominent Indian jewellers in West Asia. Mannai and Egyptian investment bank EFG Hermes acquired Damas, previously listed on Nasdaq Dubai, for $445 million in 2012. Mannai, owned by Qatar's AI Thani royal family, acquired EFG's 19% stake in Damas in 2014. Titan, a joint venture between Tata Group and Tamil Nadu Industrial Development Corporation, has the option to purchase the remaining 33% stake in Damas from Mannai after Dec 31, 2029, subject to specific conditions. The 67% stake valuation is based on Damas' enterprise value of AED 1,038 million ($283 million or Rs 2,440 crore), including debt, according to Titan, whose name combines "Ti" from Tata Industries and "Tan" from Tamil Nadu. This acquisition ranks as Titan's second-largest, following the purchase of Indian jewellery retailer CaratLane for Rs 5,038 crore ($584 million) between 2016 and 2024. Dubai-based Damas, established in 1907, operates 146 stores across six GCC countries: UAE, Saudi Arabia, Qatar, Oman, Kuwait and Bahrain. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo The agreement with Mannai excludes the franchisee business of British jewellery brand Graff, said Titan, ranked second in market value at Rs 3 lakh crore within the Tata Group, after TCS at Rs 11.4 lakh crore. 146 stores across 6 Gulf countries Despite the significant Indian diaspora in West Asia traditionally favouring gold investments, Titan plans to utilise Damas to expand its reach to diverse nationalities and ethnic groups. "Titan's acquisition of Damas is more than expansion - it's a bold attempt to rewrite the rules of luxury retail in the GCC," said Thomas Kuruvilla, Arthur D Little's managing partner for Middle East & India. "By moving beyond the Indian diaspora and acquiring a culturally iconic Arab brand, Titan is challenging entrenched European players on their turf. But this shift from familiarity to ambition is risky. Can Titan scale Damas without diluting its authenticity? This move could either be a masterstroke in globalisation - or a cautionary tale in cultural overreach," said Kuruvilla. Indian jewellers with presence in the GCC include Kalyan Jewellers, Joyalukkas, and Malabar Gold & Diamonds. Titan began selling Tanishq jewellery in the GCC in 1993, according to its website, experiencing varied success. In 2020, it launched its Dubai Tanishq store and now maintains 15 outlets in the GCC. "After successfully establishing Tanishq in the GCC and the US, our ambition for a global jewellery play is moving to the next stage. With the Damas acquisition, Titan is stepping out from its diaspora focus into other nationalities and ethnicities," said Titan's MD C K Venkataraman. "The acquisition not only creates a significant new global opportunity for Titan, but also enhances its overall position in the jewellery market in the GCC. " Mannai will use the proceeds to support expansion of its core trade and IT services businesses while reducing debt, CEO Alekh Grewal said. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

ADIA invests $200 million in medical devices co Meril
ADIA invests $200 million in medical devices co Meril

Time of India

time14 minutes ago

  • Time of India

ADIA invests $200 million in medical devices co Meril

Representative image NEW DELHI: Abu Dhabi Investment Authority (ADIA), UAE's largest sovereign wealth fund, has entered into a definitive agreement to invest $200 million (around Rs 1,700 crore) for a 3% stake in Meril (Micro Life Sciences), a medical devices company. This investment values Meril at an enterprise value of $6.6 billion (around Rs 56,000 crore), says a company statement. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this deal, Meril will be backed by two globally recognised investors — ADIA and Warburg Pincus, it adds. In 2022, Warburg Pincus announced that it will invest $210 million for a minority stake in Meril. Sanjeev Bhatt, senior vice president — strategy, Meril, said: 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. This investment will enable us to accelerate growth, attract worldclass talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Founded by the Bilakhia Group, Meril has a strong focus on clinically-advanced solutions across multiple specialties — including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical robotics. Headquartered in Vapi (Gujarat), Meril operates state-of-theart, vertically integrated, and globally certified manufacturing and R&D facilities. Established in 1976, ADIA is a globally diversified investment institution that invests funds on behalf of the Abu Dhabi govt through a strategy focused on long-term value creation. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store